Evidence map›Paper›PMID 34149710›Full record

ArticleFrontiers in immunology2021

CD3

Nur Diyana Mohd Shukri, Aziz Farah Izati, Wan Syamimee Wan Ghazali, Che Maraina Che Hussin, Kah Keng Wong

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Recent Insights Into Targeting Interleukin-27 in Coronary Artery Disease.Journal of cardiovascular translational research · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Increased IL-23RFrontiers in immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nur Diyana Mohd ShukriDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia.
Aziz Farah IzatiDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia.
Wan Syamimee Wan GhazaliHospital Universiti Sains Malaysia, Kubang Kerian, Malaysia.
Che Maraina Che HussinDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia.
Kah Keng WongDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia.
Hospital Universiti Sains Malaysia · MYUniversiti Sains Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The receptors for IL-35, IL-12Rβ2 and gp130, have been implicated in the inflammatory pathophysiology of autoimmune diseases. In this study, we set out to investigate the serum IL-35 levels and the surface levels of IL-12Rβ2 and gp130 in CD3

Indexed as

AdultCD3 ComplexCD4 AntigensCytokine Receptor gp130FemaleFlow CytometryHumansInterleukinsLupus Erythematosus, SystemicMaleMiddle AgedReceptors, CCR7Receptors, Interleukin-12Severity of Illness IndexT-Lymphocytes, RegulatoryT-Lymphocyte SubsetsCCR7 protein, humanCD3 ComplexCD4 AntigensCytokine Receptor gp130IL12RB2 protein, humaninterleukin-35, humanInterleukinsReceptors, CCR7Receptors, Interleukin-12gp130IL-12Rβ2IL-35IL6STSLEDAI-2Ksystemic lupus erythematosus

Identifiers

PMID34149710
PMCPMC8213373
OpenAlexW3169290549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.